NCT04664569 National Bacterial Meningitis Study in Children and Newborns
| NCT ID | NCT04664569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne |
| Condition | Meningitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2001-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2001-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.
Eligibility Criteria
Inclusion Criteria: * clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL). * purpura fulminans Exclusion Criteria: \-
Contact & Investigator
Corinne Levy, MD
STUDY DIRECTOR
Association Clinique Thérapeutique Infantile du val de Marne
Frequently Asked Questions
Who can join the NCT04664569 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Meningitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04664569 currently recruiting?
Yes, NCT04664569 is actively recruiting participants. Contact the research team at corinne.levy@activ-france.fr for enrollment information.
Where is the NCT04664569 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT04664569 clinical trial?
NCT04664569 is sponsored by Association Clinique Thérapeutique Infantile du val de Marne. The principal investigator is Corinne Levy, MD at Association Clinique Thérapeutique Infantile du val de Marne. The trial plans to enroll 10,000 participants.